RKIP also known as PEBP1 is a member of the phosphatidylethanolamine-binding family of proteins and has been shown to modulate multiple signaling pathways, including the MAP kinase (MAPK), NF-kappa B, and glycogen synthase kinase-3 (GSK-3) signaling pathways. RKIP plays a crucial role in regulating the MAP kinase signaling pathway, which is essential for various cellular processes such as proliferation, differentiation, and apoptosis. RKIP is primarily located in the cytosol, where RKIP interacts with key signaling molecules, including the serine/threonine kinase Raf-1. By binding to both active and inactive forms of Raf-1, RKIP modulates the activity of downstream effectors like MEK and ERK, thereby influencing cellular responses to growth factors and stress signals. RKIP′s ability to inhibit MEK activation by competing with its substrate is particularly important, as this mechanism helps maintain the balance of signaling pathways that can lead to oncogenic transformation when dysregulated.